Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04408118
Title First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin) in mTNBC (ATRACTIB)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors MedSIR
Age Groups: adult | senior
Covered Countries ITA | FRA | ESP | DEU

No variant requirements are available.